Your browser doesn't support javascript.
loading
PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis.
Xu, Dan; Bhattacharyya, Swati; Wang, Wenxia; Ifergan, Igal; Wong, Ming-Yi Alice Chiang; Procissi, Daniele; Yeldandi, Anjana; Bale, Swarna; Marangoni, Roberta Goncalves; Horbinski, Craig; Miller, Stephen D; Varga, John.
  • Xu D; Department of Microbiology-Immunology and.
  • Bhattacharyya S; Northwestern Scleroderma Program, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Wang W; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Ifergan I; Northwestern Scleroderma Program, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Wong MAC; Department of Neurological Surgery.
  • Procissi D; Department of Microbiology-Immunology and.
  • Yeldandi A; Department of Microbiology-Immunology and.
  • Bale S; Department of Radiology, and.
  • Marangoni RG; Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Horbinski C; Northwestern Scleroderma Program, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Miller SD; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Varga J; Northwestern Scleroderma Program, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
JCI Insight ; 7(5)2022 03 08.
Article en En | MEDLINE | ID: mdl-35104243

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Nanopartículas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Nanopartículas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article